Current evidence on the relationships among five polymorphisms in the matrix metalloproteinases genes and prostate cancer risk

Sci Rep. 2024 May 18;14(1):11355. doi: 10.1038/s41598-024-62016-z.

Abstract

Matrix metalloproteinases (MMPs) had a variety of subtypes, which may be related to tumor invasion and angiogenesis, and the polymorphisms from MMPs have been also associated with the susceptibility to a variety of tumors, including prostate cancer (PCa). However, previous studies have not systematically analyzed the association between MMP and prostate cancer, so we conducted systematic data collection and analyzed to evaluate the relationship among polymorphisms in MMPs and PCa susceptibility. We searched PubMed, Web of Science, Embase and Google Scholar for all papers published up to Apr 3rd, 2023, and systematically analyzed the relationship among MMP1-1607 2G/1G, MMP2-1306 T/C, MMP2-735 T/C, MMP7-181 G/A, MMP9-1562 T/C and PCa susceptibility using multiple comparative models and subgroup analyses. We found that MMP2-1306 T/C polymorphism showed associations with PCa susceptibility, with the Ethnicity subgroup (Asian) being more pronounced. Similarly, MMP9-1562 T/C has also had associations with PCa susceptibility. Our current study found that the polymorphisms of, MMP2-1306 T/C, and MMP9-1562 T/C had strong associations with PCa risk.

Keywords: Matrix metalloproteinases (MMPs); Meta-analysis; Polymorphism; Prostate cancer; Tumor marker.

Publication types

  • Meta-Analysis

MeSH terms

  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Matrix Metalloproteinase 1 / genetics
  • Matrix Metalloproteinase 2* / genetics
  • Matrix Metalloproteinase 7 / genetics
  • Matrix Metalloproteinase 9* / genetics
  • Matrix Metalloproteinases / genetics
  • Polymorphism, Single Nucleotide*
  • Prostatic Neoplasms* / genetics
  • Risk Factors

Substances

  • MMP9 protein, human
  • MMP2 protein, human